You are here: Industry Insights > Pfizer

News List

Recovered COVID-19 patients may need only one shot of mRNA vaccines, say scientists expresspharma
February 05, 2021
People who have recovered from the novel coronavirus infection may need only one shot as opposed to the recommended two jabs if they are taking the Moderna or Pfizer COVID-19 vaccines, according to a study which suggests ways to minimise doses when ...
Malaysia sets February 2022 target to complete COVID-19 vaccine rollout expresspharma
February 05, 2021
Malaysia’s government said on Thursday it expects to complete its COVID-19 immunisation programme by February next year, covering 80 per cent of its population of about 32 million people.
Patients gain early access to Pfizer's atopic dermatitis drug pharmatimes
February 04, 2021
People living in the UK with severe atopic dermatitis are to be given early access to Pfizer's abrocitinib following a green light by the Medicines and Healthcare products Regulatory Agency (MHRA).
Imcyse, Pfizer Enter Autoimmune Research Alliance contractpharma
February 04, 2021
Imcyse has entered into a research collaboration and license agreement with Pfizer Inc. for Imcyse's Rheumatoid Arthritis (RA) program based on the company's Imotope technology.
New Zealand approves COVID-19 vaccine, warns against nationalism expresspharma
February 04, 2021
The World Health Organization has warned against “hoarding” as a growing number of countries agreed bilateral deals to buy millions of doses of COVID-19 vaccines.
Pfizer targets at least 2 billion COVID-19 vaccine doses this year, sees $15 billion in 2021 from the shots expresspharma
February 04, 2021
Pfizer said that it expects to generate $15 billion, or about a quarter of its total revenue this year, from sales of its COVID-19 vaccine co-developed with German partner BioNTech.
In vitro studies demonstrate Pfizer and BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with key mutations present in U.K. and South African variants worldpharmanews
February 03, 2021
Pfizer Inc. and BioNTech SE announced results from in vitro neutralization studies of sera from individuals vaccinated with the Pfizer-BioNTech COVID-19 vaccine.
Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine contractpharma
February 01, 2021
Novartis to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of COVID-19 vaccine.
Novavax COVID-19 vaccine 89 per cent effective in UK trial, 60 per cent in South Africa expresspharma
January 29, 2021
Novavax is stockpiling vaccine at six operating manufacturing locations and said it expects a total of eight plants in seven countries to produce at the rate of two billion doses per year, including from the Serum Institute of India.
Pharma companies move towards systematic access planning approaches: 2021 Access to Medicine Index expresspharma
January 27, 2021
A new shift in pharma company policy could shorten the time people in lower-income countries must typically wait for new medicines and vaccines, reports the 2021 Access to Medicine Index.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page